Results 51 to 60 of about 3,983,713 (283)

Overdose experiences among injection drug users in Bangkok, Thailand

Harm Reduction Journal, 2010
Background Although previous studies have identified high levels of drug-related harm in Thailand, little is known about illicit drug overdose experiences among Thai drug users.
Wood Evan, Kaplan Karyn, Suwannawong Paisan, Hayashi Kanna, Fairbairn Nadia, Milloy M-J, Kerr Thomas   +6 more
doaj   +1 more source

Therapeutic drug monitoring in drug overdose [PDF]

British Journal of Clinical Pharmacology, 1999
The treatment of poisoned patients is still largely defined by history, clinical assessment and interpretation of ancillary investigations. Measurement of drug concentrations is clinically important for relatively few compounds. Most measurements form an adjunct to and should not be considered a substitute for clinical assessment.
A H, Dawson, I M, Whyte
openaire   +5 more sources

Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018

JAMA Network Open, 2022
This cohort study describes the death rates and drug types involved in fatal drug overdoses in the past 15 years among individuals experiencing homelessness in Boston, Massachusetts.
Danielle R. Fine, Kirsten A Dickins, Logan Adams, Denise de Las Nueces, Karen Weinstock, Joseph Wright, Jessie M. Gaeta, Travis P. Baggett   +7 more
semanticscholar   +1 more source

Harm reduction among injecting drug users - evidence of effectiveness [PDF]

, 2010
This chapter synthesises and evaluates the available direct evidence relating to the impact of needle and syringe programmes (NSPs), opioid substitution treatment (OST), drug consumption rooms (DCRs), and peer naloxone distribution (PND) on HIV/hepatitis
Goldberg, David, Hickman, Matthew, Hutchinson, Sharon, Kimber, Jo, Palmateer, Norah, Rhodes, Tim   +5 more
core   +1 more source

Comparison of Characteristics of Deaths From Drug Overdose Before vs During the COVID-19 Pandemic in Rhode Island

JAMA Network Open, 2021
Key Points Question Were there changes in the rate and characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island?
Alexandria Macmadu, Sivakumar Batthala, Annice M Correia Gabel, M. Rosenberg, Rik Ganguly, Jesse L. Yedinak, B. Hallowell, Rachel P. Scagos, E. Samuels, M. Cerdá, Kimberly Paull, B. Marshall   +11 more
semanticscholar   +1 more source

Urban-Rural Differences in Drug Overdose Death Rates, 1999-2019.

NCHS data brief, 2021
Drug overdose death rates continue to rise in the United States (1-3), with significant urban-rural differences in rates by sex, age, and types of drugs involved (4).
H. Hedegaard, M. Spencer
semanticscholar   +1 more source

New psychoactive substances (NPS) identified in Canada: Results of the online NPS survey (2020–2023)

Emerging Trends in Drugs, Addictions, and Health
Purpose and scope: New psychoactive substances (NPS) are a broad class of compounds that are typically designed to mimic illicit substances and circumvent legislative controls.
Sophie Rymill, Lexy Candler, Pavitra Ramachandran, Chantal Bacev-Giles, Raymond-Jonas Ngendabanka, Stephane Racine, Nancy He, Michelle Ross, Susantha Mohottalage   +8 more
doaj   +1 more source

Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths — 23 States and the District of Columbia, 2019–2020

MMWR. Morbidity and mortality weekly report, 2022
Gabapentin is an anticonvulsant medication, which is also approved by the Food and Drug Administration to treat postherpetic neuralgia, a painful complication of shingles, which results from reactivation of the varicella zoster virus.*,† Gabapentin is ...
C. Mattson, Farnaz Chowdhury, T. P. Gilson   +2 more
semanticscholar   +1 more source

Physicians’ Self-Reported Knowledge and Behaviors Related to Prescribing Opioids for Chronic Pain and Diagnosing Opioid Use Disorder, DocStyles, 2020

AJPM Focus
Introduction: In 2016, the Centers for Disease Control and Prevention released the Guideline for Prescribing Opioids for Chronic Pain (2016 Centers for Disease Control and Prevention Guideline) to improve opioid prescribing while minimizing associated ...
Kathleen R. Ragan-Burnett, MSPH, C. Robinette Curtis, MD, Kristine M. Schmit, MD, Christina A. Mikosz, MD, Lyna Z. Schieber, MD, Gery P. Guy, Jr, PhD, Tamara M. Haegerich, PhD   +6 more
doaj   +1 more source

Understanding Fatal and Non-Fatal Drug Overdose Risk Factors: Overdose Risk Questionnaire Pilot Study—Validation

Frontiers in Pharmacology, 2021
Background: Drug overdoses (fatal and non-fatal) are among the leading causes of death in population with substance use disorders. The aim of the current study was to identify risk factors for fatal and non-fatal drug overdose for predominantly opioid ...
Radhouene Doggui, Keyrellous Adib, Alex Baldacchino   +2 more
doaj   +1 more source